Your browser doesn't support javascript.
loading
Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells.
Iskandarani, Ahmad; Bhat, Ajaz A; Siveen, Kodappully S; Prabhu, Kirti S; Kuttikrishnan, Shilpa; Khan, Muzammil A; Krishnankutty, Roopesh; Kulinski, Michal; Nasr, Rihab R; Mohammad, Ramzi M; Uddin, Shahab.
Afiliação
  • Iskandarani A; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, State of Qatar. AIskandarani@hamad.qa.
  • Bhat AA; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, State of Qatar. ajaz.bhatt@gmail.com.
  • Siveen KS; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, State of Qatar. SSivaraman@hamad.qa.
  • Prabhu KS; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, State of Qatar. KPrabhu@hamad.qa.
  • Kuttikrishnan S; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, State of Qatar. SKuttikrishnan@hamad.qa.
  • Khan MA; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, State of Qatar. MKhan39@hamad.qa.
  • Krishnankutty R; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, State of Qatar. RKishnankutty@hamad.qa.
  • Kulinski M; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, State of Qatar. MKulinski@hamad.qa.
  • Nasr RR; Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut, Lebanon. rn03@aub.edu.lb.
  • Mohammad RM; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, State of Qatar. RMohammad2@hamad.qa.
  • Uddin S; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, State of Qatar. SKhan34@hamad.qa.
J Transl Med ; 14: 69, 2016 Mar 09.
Article em En | MEDLINE | ID: mdl-26956626
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Regulação para Baixo / Apoptose / Proteínas Quinases Associadas a Fase S / Bortezomib Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: J Transl Med Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Regulação para Baixo / Apoptose / Proteínas Quinases Associadas a Fase S / Bortezomib Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: J Transl Med Ano de publicação: 2016 Tipo de documento: Article